THE SPEAK FOUNDATION IS AN INTERNATIONAL ORGANIZATION FOR LGMD

The Speak Foundation
The Speak Foundation
  • Home
  • About Us
  • Limb-Girdle Magazine
  • LGMD Patient Network
  • PFDD
  • Donate
  • Programs
    • GLOBAL ADVOCACY SUMMIT
    • LGMD CONFERENCE
    • LGMD EDUCATION
    • GRANT PROGRAMS
    • COVID-19 RESOURCES
  • Advocacy
  • Partnerships
  • JOIN OUR MISSION
    • VOLUNTEER
  • Contact Us
  • More
    • Home
    • About Us
    • Limb-Girdle Magazine
    • LGMD Patient Network
    • PFDD
    • Donate
    • Programs
      • GLOBAL ADVOCACY SUMMIT
      • LGMD CONFERENCE
      • LGMD EDUCATION
      • GRANT PROGRAMS
      • COVID-19 RESOURCES
    • Advocacy
    • Partnerships
    • JOIN OUR MISSION
      • VOLUNTEER
    • Contact Us
  • Home
  • About Us
  • Limb-Girdle Magazine
  • LGMD Patient Network
  • PFDD
  • Donate
  • Programs
  • Advocacy
  • Partnerships
  • JOIN OUR MISSION
  • Contact Us


WE NEED YOU!

Join us September 23, 2022, when we meet with the FDA and other stakeholders about our needs as a patient community!


The goal of this meeting is to provide the U.S. Food and Drug Administration (FDA), product developers, clinicians, industry, and academic researchers an opportunity to hear perspectives from individuals with LGMD on the health effects, daily impacts, treatment goals, and decision factors considered when seeking out or selecting a treatment. This meeting is being conducted as a parallel effort to FDA’s EL-PFDD initiative, a commitment under the fifth authorization of the Prescription Drug User Fee Act (PDUFA V) to more systematically gather patients’ perspectives on their conditions and available therapies to treat their conditions.


  • What will happen at this EL-PFDD meeting?  This important, monumental effort will give individuals diagnosed with limb-girdle muscular dystrophy types 2A, 2C, 2D, 2E, 2F, and 2I an opportunity to share with the FDA and other stakeholders about the experiences and challenges of living with LGMD. 
  • Where will the meeting take place?  The meeting will take place virtually and will be live.  Participants will be able to watch the event as it occurs.  
  • How can I get involved?  You will also be able to participate in polling and participate in surveys prior to the event to share your needs as an individual living with LGMD.  Many individuals will be selected to speak to the FDA and other stakeholders either through prerecorded video or during live segments in the EL-PFDD.
  • What do we hope to gain?  The EL-PFDD meeting is designed to engage patients and elicit their unique perspectives. With this information, our goal is to enable the FDA and the whole drug development community to understand the needs of our patient community and our expectations for future treatments. The meeting will be summarized in a Voice of the Patient report. The report, as well as recorded footage of the meeting, will be publicly available.

 

Please note that this initial endeavor represents Phase 1 and will include six LGMD subtypes.  We anticipate additional LGMD subtypes will pursue EL-PFDD meetings in the future.

Do you want to help us make historical changes for the limb-girdle community?

 

If so, we need your voice! Simply click on the button below to help. The subtypes of 2A, 2C, 2D, 2E, 2F, and 2I will be highlighted in this first phase of the EL-PFDD meeting.

I would like more information.

Our LGMD Coalition

Our Sponsors

Copyright © 2008 The Speak Foundation, The Limb Girdle Muscular Dystrophy Foundation - All Rights Reserved.

The Speak Foundation is a 501(c)(3), Est. 2008.

  • LGMD Patient Network
  • Contact Us

Sign Up Today!

Sign up to be included in the Limb Girdle Muscular Dystrophy Patient Network where you will receive cutting edge research updates from the leading experts in the world such as the GRASP LGMD consortium and also be invited to hear about new clinical trials.  When you sign up here, you will also receive the free LGMD News Magazine if you live in the USA.  Anyone can join the LGMD Patient Network.